SIRT6 and liver cancer: Another study showed that knockdown of SIRT6 significantly promoted clone formation ability in the HuH7 cell (human liver cancer cells), and SIRT6 overexpression inhibited cell clone formation through inhibition of the ERK1/2 signaling pathway (Wang, Lan, et al., 2022).